Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages 150-155

  Yang, Dan Li ^a,b   Zhang, Hai Gang ^a   Xu, Ya Li ^a   Gao, Yun Hua ^a   Yang, Xiao Jiao ^a   Hao, Xue Qin ^a   Li, Xiao Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Monocrotaline; Pulmonary hypertension; Resveratrol; Right ventricular remodelling

Indexed keywords

MONOCROTALINE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ECHOCARDIOGRAPHY; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART PROTECTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; RAT;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; HEART; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MONOCROTALINE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 75649149810     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05231.x     Document Type: Article

References (31)

1. Kret M, Arora R. Pathophysiological basis of right ventricular remodeling. J. Cardiovasc. Pharmacol. Ther. 2007 12 : 5 14.
2. Voelkel NF, Quaife RA, Leinwand LA et al. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute Working Group on cellular and molecular mechanisms of right heart failure. Circulation 2006 114 : 1883 1891.
3. 2+ concentrations are involved in resveratrol protection against apoptosis in rat primary neuron cultures. Acta Pharmacol. S2007 28 : 1724 1730.
4. German JB, Walzem RL. The health benefits of wine. Annu. Rev. Nutr. 2000 20 : 561 593.
5. Das DK, Maulik N. Resveratrol in cardioprotection: A therapeutic promise of alternative medicine. Mol. Interv. 2006 6 : 36 47.
6. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic. Biol. Med. 1999 27 : 160 169.
7. Chen YR, Yi FF, Li XY et al. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc. Drugs Ther. 2008 22 : 479 485.
8. Das S, Khan N, Mukherjee S et al. Redox regulation of resveratrol-mediated switching of death signal into survival signal. Free Radic. Biol. Med. 2008 44 : 82 90.
9. Cheng TH, Liu JC, Lin H et al. Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn Schmiedebergs Arch. Pharmacol. 2004 369 : 239 244.
10. Chan AY, Dolinsky VW, Soltys CL et al. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J. Biol. Chem. 2008 283 : 24194 24201.
11. Wang S, Wang X, Yan J et al. Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: Correlated with NO-cGMP signaling pathway. Eur. J. Pharmacol. 2007 567 : 26 35.
12. Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H1131 8.
13. Juric D, Wojciechowski P, Das DK, Netticadan T. Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am. J. Physiol. Heart Circ. Physiol. 2007 292 : H2138 43.
14. Liu Z, Song Y, Zhang X et al. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. ClExp. Pharmacol. Physiol. 2005 32 : 1049 1054.
15. Jones JE, Mendes L, Rudd MA, Russo G, Loscalzo J, Zhang YY. Serial noninvasive assessment of progressive pulmonary hypertension in a rat model. Am. J. Physiol. Heart Circ. Physiol. 2002 283 : H364 71.
16. Clozel M, Hess P, Rey M, Iglarz M, Binkert C, Qiu C. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. Exp. Biol. Med. 2006 231 : 967 973.
17. Jiang QS, Huang XN, Dai ZK et al. Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat. J. Ethnopharmacol. 2007 111 : 567 572.
18. Chen QM, Tu VC, Purdon S, Wood J, Dilley T. Molecular mechanisms of cardiac hypertrophy induced by toxicants. Cardiovasc. Toxicol. 2001 1 : 267 283.
19. Campian ME, Hardziyenka M, Michel MC, Tan HL. How valid are animal models to evaluate treatments for pulmonary hypertension? Naunyn Schmiedebergs Arch. Pharmacol. 2006 373 : 391 400.
20. Kasahara Y, Kiyatake K, Tatsumi K et al. Bioactivation of monocrotaline by P-450 3A in rat liver. J. Cardiovasc. Pharmacol. 1997 30 : 124 129.
21. Qin N, Gong QH, Wei LW, Wu Q, Huang XN. Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats. Biol. Pharm. Bull. 2008 31 : 1530 1535.
22. McMurtry MS, Bonnet S, Wu X et al. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ. Res. 2004 95 : 830 840.
23. Laudi S, Trump S, Schmitz V et al. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatAm. J. Physiol. Lung Cell. Mol. Physiol. 2007 293 : L630 8.
24. Sener G, Topaloglu N, Sehirli AO, Ercan F, Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm. Pharmacol. Ther. 2007 20 : 642 649.
25. Bussani R, Abbate A, Biondi-Zoccai GG et al. Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. J. ClPathol. 2003 56 : 672 676.
26. Anselmi A, Gaudino M, Baldi A et al. Role of apoptosis in pressure-overload cardiomyopathy. J. Cardiovasc. Med. 2008 9 : 227 232.
27. Ichas F, Mazat JP. From calcium signaling to cell death. Two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim. Biophys. Acta 1998 1366 : 33 50.
28. Gupta S, Das B, Sen S. Cardiac hypertrophy: Mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 2007 9 : 623 652.
29. Lagouge M, Argmann C, Gerhart-Hines Z et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006 127 : 1109 1122.
30. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004 73 : 417 435.
31. Howitz KT, Bitterman KJ, Cohen HY et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 : 191 196.